Insphero company
Nettet3. apr. 2024 · InSphero has uniquely positioned itself with its highly industrialized platform solution to address this market opportunity,” says Gerrit Schulte, Head of ZEISS Ventures. Dr. Jan Lichtenberg, CEO and Co-founder of InSphero, says: “The widespread use of 3D microtissues following the ratification of the FDA Modernization Act requires efficient, … NettetInSphero partners with leading biotechnology providers and academic institutions to develop 3D cell-based technologies that help our customers yield actionable insights …
Insphero company
Did you know?
Nettet1. des. 2024 · InSphero is a Swiss-based biotech company that has been perfecting 3D cell-based drug discovery platforms and scaffold-free 3D Organ-on-a-Chip technologies for more than 10 years. The company’s strategic partnering model is based on multi-tiered, custom programs with pharma, biotech and academic organizations and led to … NettetFunding. InSphero has raised a total of $35.2M in funding over 9 rounds. Their latest funding was raised on Mar 31, 2024 from a Venture - Series Unknown round. InSphero …
NettetINSPHERO 358 followers on LinkedIn. Purpose-driven & Values-based College Completion Program. INSPHERO is social enterprise that is passionate about making … NettetInSphero’s leadership team brings experience in 3D microtissue engineering, cell-based assays, industry-scale production & quality assurance. SCIENCE. ... Co-founder of …
Nettet2 dager siden · Insphero AG, a pioneer in 3D spheroid and cell-based assays in pharmaceutical drug discovery and safety testing, has raised an eight-figure amount in its latest funding round. InSphero will utilize the proceeds to commercialize its cryo-preservation technology to enable further growth and scalability. Zeiss Ventures is … Nettet31. mar. 2024 · Dr. Jan Lichtenberg, CEO and Co-founder of InSphero, says: “The widespread use of 3D microtissues following the ratification of the FDA Modernization Act requires efficient, ... InSphero is the pioneer of industrial-grade and scalable 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology.
NettetInSphero AG is a Business Services, Biotechnology Research, and Biotechnology company located in Schlieren, Zurich with $13.00 Million in revenue and 80 ... Services, supported by a comprehensive panel of 3D-optimized culture media, assay protocols, and imaging solutions. InSphero’s technologies drive significant findings in peer ...
NettetInSphero. Glassdoor gives you an inside look at what it's like to work at InSphero, including salaries, reviews, office photos, and more. This is the InSphero company … calling the hogsNettetwww.insphero.com GravityTRAPHanging Drop System & TM ULA PlateGravityTRAPTM ULA Plate 29 Summary 1. GravityPLUS™ Hanging Drop system Complete system … calling the hunting partyNettet19. mai 2024 · The scalable Akura™ technology underlying the company’s 3D InSight™ Discovery and Safety Platforms includes 96 and 384-well plate formats and the … calling the irs about refundNettetInSphero’s Profile, Revenue and Employees. InSphero is a Switzerland-based medical technology firm that develops 3D-cell-based assays and 3D organ-on-a-chip products for pharmaceutical and biotechnology researchers. InSphero’s primary competitors include Synthecon, 3D Biotek, Aspect Biosystems and 5 more. cobweb wandering dude careNettetTogether with our partners in academia and industry, InSphero advances drug discovery and our understanding of healthy and diseased human biology pioneering the 3D in … 3D InSight™ Microtissues are delivered to laboratories worldwide in assay-ready in … InSphero assay-ready 3D InSight™ Tumor Microtissues are designed to simplify … Our Solutions for Diabetes Drug Testing. The homogeneous cellular composition, … 3D InSight™ Human Liver Disease Discovery Platform models use … Read InSphero's white papers based on 3D microtissues for drug discovery & … Select from assay-ready 3D tumor models and tumor/stromal models derived from … InSphero CEO and co-founder, Jan Lichtenberg, brings extensive … InSphero's Services: Early compound de-risking and drug discovery decisions … cobweb wallpaperNettetInSphero AG is a Business Services, Biotechnology Research, and Biotechnology company located in Schlieren, Zurich with $13.00 Million in revenue and 80 ... cobweb vision in eyeNettetInSphero 6 396 følgere på LinkedIn. Innovate Investigate Discover Together InSphero provides superior biological relevance to in vitro testing with easy-to-use … cobweb upsc